| BIS |
phenotype |
7 |
6 |
Barratt Impulsiveness Scale, Behavioral Inhibition Scale, Behavioral Inhibition System, Behavioral Inhibition System scale, PKC inhibitor BIS, bisindolylmaleimide |
| BIS-11 score |
phenotype |
4 |
3 |
BIS-11, Barratt Impulsiveness Scale |
| bisulfite |
drug |
3 |
2 |
bisulfite treatment |
| bitopertin |
drug |
2 |
— |
RG1678 |
| BK channel |
gene |
3 |
3 |
BK channels, KCNMA1, big potassium channel, large-conductance calcium- and voltage-activated potassium channel |
| Black |
phenotype |
20 |
6 |
African American, Black, Black adolescents, Black respondents, Blacks, black, black individuals |
| Black children |
cohort |
2 |
1 |
African American children, Black children |
| Black females |
cohort |
4 |
3 |
Black girls |
| black men |
cohort |
7 |
4 |
African American men, Black men, black males, blacks |
| black participants |
cohort |
8 |
4 |
African American, Black, Black adults, Black individuals, Black respondents, Blacks, black |
| black population |
cohort |
2 |
1 |
black population |
| blacks |
cohort |
10 |
5 |
African American, African Americans, Black, Black Americans, Black individuals, Black participants, Black population, Black respondents, Black youth, Blacks, black, black individuals, black participants |
| black women |
cohort |
3 |
1 |
Black women |
| Black youth |
cohort |
4 |
2 |
African-American, Black |
| bladder cancer |
phenotype |
8 |
2 |
bladder carcinoma |
| blindness |
phenotype |
2 |
— |
|
| block 1 |
variant |
2 |
— |
|
| blood |
drug |
20 |
9 |
blood sample, blood tissue |
| blood alcohol concentration |
phenotype |
11 |
9 |
BAC, BACs in the range of 100 mg%, BACs over 80 mg%, BrAC, aggregated BAC, blood alcohol level, blood alcohol levels, blood ethanol levels, gold standard BAC, raw BAC reading, silver standard BAC |
| blood alcohol concentration (BAC) |
phenotype |
4 |
5 |
BAC, Peak BAC |
